Inhibition of MAN2A1 Enhances the Immune Response to Anti–PD-L1 in Human Tumors
Sign Up to like & getrecommendations! Published in 2020 at "Clinical Cancer Research"
DOI: 10.1158/1078-0432.ccr-20-0778
Abstract: Purpose: Immune checkpoint blockade has shown remarkable efficacy, but in only a minority of patients with cancer, suggesting the need to develop additional treatment strategies. Aberrant glycosylation in tumors, resulting from the dysregulated expression of… read more here.
Keywords: immune response; human tumors; treatment; man2a1 ... See more keywords